Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2006 | 2018 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.200 | 7 | 101126257 | upstream gene variant | A/G | snv | 0.54 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 7 | 101138164 | 3 prime UTR variant | T/G | snv | 0.44 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.120 | 7 | 101133986 | intron variant | T/C | snv | 0.44 |
|
Eye Diseases; Endocrine System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
7 | 101129564 | intron variant | G/A | snv | 0.32 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
7 | 101129564 | intron variant | G/A | snv | 0.32 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.807 | 0.200 | 7 | 101128436 | missense variant | G/A | snv | 9.5E-02 | 8.0E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.807 | 0.200 | 7 | 101128436 | missense variant | G/A | snv | 9.5E-02 | 8.0E-02 |
|
0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.807 | 0.200 | 7 | 101128436 | missense variant | G/A | snv | 9.5E-02 | 8.0E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.807 | 0.200 | 7 | 101128436 | missense variant | G/A | snv | 9.5E-02 | 8.0E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.807 | 0.200 | 7 | 101128436 | missense variant | G/A | snv | 9.5E-02 | 8.0E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.807 | 0.200 | 7 | 101128436 | missense variant | G/A | snv | 9.5E-02 | 8.0E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||
|
1.000 | 0.040 | 7 | 101128442 | missense variant | G/A | snv | 2.9E-02 | 3.3E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
7 | 101138800 | 3 prime UTR variant | T/C | snv | 1.2E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |